In the light of the newly shaped entity of high-grade B-Cell lymphoma with MYC, BCL2 and or BCL6 aberrations, which was excluded from the current study, however, this was to be expected. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.